Understanding the burden of pneumococcal disease in adults

F. Blasi, M. Mantero, Pierachille Santus, P. Tarsia

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Streptococcus pneumoniae causes different types of acute, invasive and non-invasive clinical infections, being the most frequently detected pathogen responsible for community-acquired pneumonia. Pneumococcal pneumonia is accompanied by bacteraemia in 10-30% of cases. Streptococcus pneumoniae is gaining resistance to the in vitro activity of several antimicrobial agents and, even if questions remain regarding the clinical impact of this phenomenon, more and more reports indicate that antibiotic resistance can lead to more treatment failures if not higher mortality. Use of the 23-valent anti-pneumococcal vaccine appears to offer subpotimal protection against pneumococcal disease, particularly among high-risk adult populations. Vaccination against S. pneumoniae with new conjugate vaccines seems to be the most promising field for real improvement in the management of pneumococcal infections in adults.

Original languageEnglish
Pages (from-to)7-14
Number of pages8
JournalClinical Microbiology and Infection
Volume18
Issue numberSUPPL. 5
DOIs
Publication statusPublished - Oct 2012

Fingerprint

Streptococcus pneumoniae
Pneumococcal Pneumonia
Pneumococcal Infections
Conjugate Vaccines
Pneumococcal Vaccines
Microbial Drug Resistance
Bacteremia
Anti-Infective Agents
Treatment Failure
Pneumonia
Vaccination
Mortality
Infection
Population

Keywords

  • Antibiotic resistance
  • Cost of disease
  • Infection prevention
  • Streptococcus pneumoniae
  • Vaccine

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Understanding the burden of pneumococcal disease in adults. / Blasi, F.; Mantero, M.; Santus, Pierachille; Tarsia, P.

In: Clinical Microbiology and Infection, Vol. 18, No. SUPPL. 5, 10.2012, p. 7-14.

Research output: Contribution to journalArticle

@article{7c3599f49d6f4303a97564806eeb78cc,
title = "Understanding the burden of pneumococcal disease in adults",
abstract = "Streptococcus pneumoniae causes different types of acute, invasive and non-invasive clinical infections, being the most frequently detected pathogen responsible for community-acquired pneumonia. Pneumococcal pneumonia is accompanied by bacteraemia in 10-30{\%} of cases. Streptococcus pneumoniae is gaining resistance to the in vitro activity of several antimicrobial agents and, even if questions remain regarding the clinical impact of this phenomenon, more and more reports indicate that antibiotic resistance can lead to more treatment failures if not higher mortality. Use of the 23-valent anti-pneumococcal vaccine appears to offer subpotimal protection against pneumococcal disease, particularly among high-risk adult populations. Vaccination against S. pneumoniae with new conjugate vaccines seems to be the most promising field for real improvement in the management of pneumococcal infections in adults.",
keywords = "Antibiotic resistance, Cost of disease, Infection prevention, Streptococcus pneumoniae, Vaccine",
author = "F. Blasi and M. Mantero and Pierachille Santus and P. Tarsia",
year = "2012",
month = "10",
doi = "10.1111/j.1469-0691.2012.03937.x",
language = "English",
volume = "18",
pages = "7--14",
journal = "Clinical Microbiology and Infection",
issn = "1198-743X",
publisher = "Elsevier B.V.",
number = "SUPPL. 5",

}

TY - JOUR

T1 - Understanding the burden of pneumococcal disease in adults

AU - Blasi, F.

AU - Mantero, M.

AU - Santus, Pierachille

AU - Tarsia, P.

PY - 2012/10

Y1 - 2012/10

N2 - Streptococcus pneumoniae causes different types of acute, invasive and non-invasive clinical infections, being the most frequently detected pathogen responsible for community-acquired pneumonia. Pneumococcal pneumonia is accompanied by bacteraemia in 10-30% of cases. Streptococcus pneumoniae is gaining resistance to the in vitro activity of several antimicrobial agents and, even if questions remain regarding the clinical impact of this phenomenon, more and more reports indicate that antibiotic resistance can lead to more treatment failures if not higher mortality. Use of the 23-valent anti-pneumococcal vaccine appears to offer subpotimal protection against pneumococcal disease, particularly among high-risk adult populations. Vaccination against S. pneumoniae with new conjugate vaccines seems to be the most promising field for real improvement in the management of pneumococcal infections in adults.

AB - Streptococcus pneumoniae causes different types of acute, invasive and non-invasive clinical infections, being the most frequently detected pathogen responsible for community-acquired pneumonia. Pneumococcal pneumonia is accompanied by bacteraemia in 10-30% of cases. Streptococcus pneumoniae is gaining resistance to the in vitro activity of several antimicrobial agents and, even if questions remain regarding the clinical impact of this phenomenon, more and more reports indicate that antibiotic resistance can lead to more treatment failures if not higher mortality. Use of the 23-valent anti-pneumococcal vaccine appears to offer subpotimal protection against pneumococcal disease, particularly among high-risk adult populations. Vaccination against S. pneumoniae with new conjugate vaccines seems to be the most promising field for real improvement in the management of pneumococcal infections in adults.

KW - Antibiotic resistance

KW - Cost of disease

KW - Infection prevention

KW - Streptococcus pneumoniae

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=84867397202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867397202&partnerID=8YFLogxK

U2 - 10.1111/j.1469-0691.2012.03937.x

DO - 10.1111/j.1469-0691.2012.03937.x

M3 - Article

C2 - 22882668

AN - SCOPUS:84867397202

VL - 18

SP - 7

EP - 14

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - SUPPL. 5

ER -